Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KZR will decline by -1.19% over the next 2 Weeks and hit $7.20 by Friday, May 22, 2026. In that time frame, KZR's share price is expected to range between $6.94 and $7.47.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 22, 2026 | 6.92 | 7.19 | 7.46 |
| May 21, 2026 | 7.15 | 7.43 | 7.69 |
| May 20, 2026 | 7.14 | 7.40 | 7.69 |
| May 19, 2026 | 7.14 | 7.40 | 7.68 |
| May 18, 2026 | 7.19 | 7.45 | 7.71 |
| May 15, 2026 | 6.90 | 7.17 | 7.44 |
| May 14, 2026 | 7.15 | 7.42 | 7.67 |
| May 13, 2026 | 7.10 | 7.39 | 7.65 |
| May 12, 2026 | 7.12 | 7.39 | 7.65 |
| May 11, 2026 | 7.18 | 7.44 | 7.73 |
KZR shares remained flat 0 in Monday, May 11, 2026's trading session, starting and closing at a previous close of $7.29 to move at $7.29. The stock demonstrated notable intraday movement (see KZR's key stats for a full breakdown), fluctuating between $7.29 and $7.29, a 0 trading range. While recent weeks have seen some volatility, KZR has managed to secure a +0.28% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 613.31K shares changing hands, 436.86K more than the previous session. This amounted to $4.47M in total market activity.
Will KZR Continue Its Upward Trend?
According to analyst ratings and projections for KZR, Kezar Life Sciences, Inc. shares are anticipated to increase by +2.25%, potentially reaching $7.46 per share by May 22, 2026. Short-term technical indicators currently suggest a neutral sentiment for KZR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the KZR stock forecast, now is a good time to buy KZR stock because its current trading price is +1.43% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KZR covering social and institutional perspectives.
KZR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KZR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.97% to 54.94%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 57.02%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 48.39%, maintains a neutral outlook for the long term. Insights into KZR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Kezar Life Sciences, Inc. Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Kezar Life Sciences, Inc. (KZR) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $3.61, settling at an average of $0.03. This could translate to a -99.59% loss.
July 2026
Based on current market signals, Kezar Life Sciences, Inc. is projected to trend july 2026. We forecast a trading range from $0.00 to $3.72, with a likely average price of $0.03. Investors could expect a potential return of -99.59%.
August 2026
Our predictive algorithms indicate Kezar Life Sciences, Inc. stock may see a shift in August 2026. The expected range spans $0.00–$3.55, with an average target of $0.02. This represents a cautious outlook and a possible loss of -99.73%.
September 2026
Analyzing established trends, Kezar Life Sciences, Inc. looks set to move in September 2026. Projections place the stock between $0.00 and $3.62, averaging around $0.02. This suggests a -99.73% loss from current levels.
October 2026
Market indicators suggest Kezar Life Sciences, Inc. could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $3.48, with a midpoint forecast of $0.01. The stock might deliver a -99.86% loss.
November 2026
Forecasting for November 2026, models estimate that Kezar Life Sciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.37, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
December 2026
According to our latest forecast models, Kezar Life Sciences, Inc. (KZR) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $3.52, settling at an average of $0.00. This could translate to a -100.00% loss.
January 2027
Based on current market signals, Kezar Life Sciences, Inc. is projected to trend january 2027. We forecast a trading range from $0.00 to $3.24, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
February 2027
Our predictive algorithms indicate Kezar Life Sciences, Inc. stock may see a shift in February 2027. The expected range spans $0.00–$3.35, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
March 2027
Analyzing established trends, Kezar Life Sciences, Inc. looks set to move in March 2027. Projections place the stock between $0.00 and $3.55, averaging around $0.00. This suggests a -100.00% loss from current levels.
April 2027
Market indicators suggest Kezar Life Sciences, Inc. could experience notable changes during April 2027. Prices could fluctuate within $0.00 to $3.56, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
May 2027
Forecasting for May 2027, models estimate that Kezar Life Sciences, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.35, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
KZR's history of dividends and stock splits also plays a role in long-term investor confidence.